News about Global Pharma

WHO Validates Timor-Leste's Elimination of Trachoma as Public Health Problem

WHO validates Timor-Leste’s elimination of trachoma, making it the 33rd country globally to achieve the milestone and ending the disease’s public health status across the South-East Asia Region.

Global Pharma | 04/09/2026 | By News Bureau

RPG Life Sciences Subsidiary to Acquire Raghava Life Sciences' API Business for Up to INR 135 Crore

RPG Active Pharma’s latest acquisition expands its manufacturing capacity, API portfolio and regulatory capabilities as part of its buy-and-build strategy.

Global Pharma | 03/09/2026 | By Akanki

Sanner Group Appoints New CBDO to Accelerate Global Growth Strategy

Sanner Group appoints Jean-Edouard Rabier as Chief Business Development Officer (CBDO) to accelerate its global growth strategy, leveraging his 20+ years of pharmaceutical and healthcare experience.

Global Pharma | 03/09/2026 | By News Bureau

Syntegon Opens New OSD Customer Center in Fellbach

Syntegon opens a new state-of-the-art OSD Customer Center in Fellbach to drive innovation and accelerate time-to-market for pharma and nutraceutical products.

Global Pharma | 03/09/2026 | By News Bureau

Teva Pharma and Trump Administration Plan Agreement on Affordable Medicines

Teva Pharma plans an agreement with the Trump Administration to align US Medicaid pricing for select medicines with leading developed markets under the GENEROUS framework.

Global Pharma | 02/09/2026 | By News Bureau

Sun Pharma Participates in White House Signing Ceremony Highlighting US Medicines Pricing and Access Commitments

Sun Pharma joins White House ceremony highlighting US medicines pricing and access commitments, strengthening its presence across dermatology, immunology and generics.

Global Pharma | 01/09/2026 | By News Bureau

RNA Breakthrough Offers Hope for Thousands of Untreatable Diseases

Researchers at University of Toronto, University Health Network and SickKids develop engineered tRNA as a potential RNA therapeutic platform for thousands of untreatable diseases.

Global Pharma | 31/08/2026 | By News Bureau

AbbVie Seeks EMA Approval for Subcutaneous SKYRIZI in Crohn's Disease

AbbVie submits an European Medicines Agency (EMA) application for subcutaneous SKYRIZI induction in adults with moderately to severely active Crohn’s Disease (CD), supported by phase 3 AFFIRM data.

Global Pharma | 27/08/2026 | By News Bureau

Fosun Pharma Announces 2026 Interim Results

Fosun Pharma announces its 2026 interim results, highlighting accelerating globalisation and value realisation from its innovative drug portfolio.

Global Pharma | 27/08/2026 | By News Bureau |  107

Piramal Alternatives Invests INR 215 Crore in Kolors Healthcare to Drive Wellness Business Expansion

Piramal Alternatives has invested INR 215 crore in Kolors Healthcare to accelerate clinic expansion, strengthen infrastructure and support the wellness company’s Kolors 2.0 transformation.

Global Pharma | 26/08/2026 | By News Bureau